Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson's Disease Foundation and American Parkinson Disease Association Collaborate to Cultivate Future Parkinson's Scientific Leaders

The Parkinson's Disease Foundation® (PDF®) and the American Parkinson Disease Association (APDA) are pleased to announce their collaboration on Summer Student Fellowships to support research that will help solve, treat and end Parkinson's disease. The collaboration expands opportunities for talented undergraduates and medical students to gain early exposure to careers in Parkinson's by conducting ten-week research fellowships with established leaders in the field. The collaboration reflects PDF and APDA's shared commitment to cultivating students' early interest and leadership in Parkinson's research.

"PDF and APDA share an urgency for improving the lives of the one million people in the US living with Parkinson's," said Robin Anthony Elliott, President, Parkinson's Disease Foundation. "And we know that all too often, young talented researchers — those who represent the future of our field — face challenges when beginning careers in science. We are committed to cultivating their early interest and commitment and welcoming them to the fight against Parkinson's."

Since 2002, PDF has funded nearly 200 summer student fellows, who have gone on to a variety of careers in medicine, health care and basic research. Similarly, APDA has funded more than 120 medical students through its Summer Research Fellowship program since 1984. These investments have not only enabled students to build their own research careers, but have also allowed students to contribute significantly to the Parkinson's research of established scientists with whom they work.

Through this collaboration, PDF and APDA are investing $60,000 toward Summer Student Fellowships. The collaboration offers undergraduate and medical students $4,000 in funding for Parkinson's research projects to be conducted over a ten-week period in the summer of 2016. It also expands the program by offering additional funding for qualified students to share their Parkinson's research findings with the scientific community at relevant conferences.

"This innovative partnership supports our mutual focus to inspire and invest in young scientists at a critical time in their educational and professional careers. APDA is delighted to combine efforts with PDF to ensure talented medical students are provided with important seed funding that could lead to a long term commitment to Parkinson's research while potentially helping to unlock the mysteries of this complex and devastating disease that impacts millions of families worldwide," said Leslie Chambers, President & CEO of APDA.

Thursday, October 15, 2015
New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board
Tuesday, June 26, 2018

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council
Wednesday, June 13, 2018

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council.

The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.

Delegates From The Parkinson’s Community Converge On Capitol Hill To Advocate For Critical Research Funding
Monday, March 5, 2018

—2018 Parkinson’s Policy Forum Co-Sponsored by the Parkinson’s Foundation and the Michael J. Fox Foundation for Parkinson’s Research—

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.